(Q38367997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 reference

title

Patient-derived bladder cancer xenografts: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Francisco Amado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Céu Costa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nuno Sousa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lúcio Santos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

12 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

324-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25742701%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

What we could do now: molecular pathology of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Molecularly characterised xenograft tumour mouse models: valuable tools for evaluation of new therapeutic strategies for secondary liver cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

The growth of human bladder and kidney cancers as xenografts in nude mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

The growth and histological characteristics of a series of human bladder cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Patient-derived tumour xenografts as models for oncology drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001

The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2015.02.001